Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics.

Autor: Previti S; Pôle Chime Balard, IBMM, UMR 5247 CNRS, Université Montpellier ENSCM F-34000 Montpellier France florine.cavelier@umontpellier.fr +33 448792134.; Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina Viale Stagno d'Alcontres 31 98166 Messina Italy spreviti@unime.it +39 090 676 5669., Bodin S; CNRS, EPHE, INCIA UMR 5287, University of Bordeaux F-33400 Talence France.; Department of Nuclear Medicine, CHU Bordeaux F-33000 Bordeaux France., Rémond E; Pôle Chime Balard, IBMM, UMR 5247 CNRS, Université Montpellier ENSCM F-34000 Montpellier France florine.cavelier@umontpellier.fr +33 448792134., Vimont D; CNRS, EPHE, INCIA UMR 5287, University of Bordeaux F-33400 Talence France., Hindié E; CNRS, EPHE, INCIA UMR 5287, University of Bordeaux F-33400 Talence France.; Department of Nuclear Medicine, CHU Bordeaux F-33000 Bordeaux France.; Institut Universitaire de France F-75000 Paris France., Morgat C; CNRS, EPHE, INCIA UMR 5287, University of Bordeaux F-33400 Talence France.; Department of Nuclear Medicine, CHU Bordeaux F-33000 Bordeaux France., Cavelier F; Pôle Chime Balard, IBMM, UMR 5247 CNRS, Université Montpellier ENSCM F-34000 Montpellier France florine.cavelier@umontpellier.fr +33 448792134.

Publikováno v: RSC medicinal chemistry [RSC Med Chem] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.

Exogenous C-S Lyase Enzyme, a Potential Tool To Release Aromas in Wine or Beer?

Autor: Clérat L; PhyMedExp, Inserm U1046, CNRS UMR 9214, CHU Arnaud de Villeneuve Bâtiment Crastes de Paulet, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 05, France.; Oenobrands SAS, Parc Scientifique Agropolis II, Bâtiment 5, 2196 Boulevard de la Lironde, 34980 Montferrier sur Lez, France., Rémond E; Pôle Chimie Balard, IBMM, UMR 5247 CNRS, Université Montpellier, ENSCM, 1919 Route de Mende, 34293 Montpellier Cedex 05, France., Schneider R; Oenobrands SAS, Parc Scientifique Agropolis II, Bâtiment 5, 2196 Boulevard de la Lironde, 34980 Montferrier sur Lez, France., Cavelier F; Pôle Chimie Balard, IBMM, UMR 5247 CNRS, Université Montpellier, ENSCM, 1919 Route de Mende, 34293 Montpellier Cedex 05, France., Vivès E; PhyMedExp, Inserm U1046, CNRS UMR 9214, CHU Arnaud de Villeneuve Bâtiment Crastes de Paulet, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 05, France.

Publikováno v: Journal of agricultural and food chemistry [J Agric Food Chem] 2024 Jan 31; Vol. 72 (4), pp. 1878-1884. Date of Electronic Publication: 2023 Jun 09.

Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R.

Autor: Schollhammer R; Nuclear Medicine Department, Bordeaux University Hospital, 33000 Bordeaux, France.; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France., Quintyn Ranty ML; Department of Pathology, University Hospital of Toulouse, 31000 Toulouse, France., de Clermont Gallerande H; Nuclear Medicine Department, Bordeaux University Hospital, 33000 Bordeaux, France.; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France., Cavelier F; Institut des Biomolécules Max Mousseron IBMM, UMR 5247, CNRS, Université Montpellier, ENSCM, Pôle Chimie Balard, 1919 Route de Mende, Cedex 5, 34293 Montpellier, France., Valverde IE; Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 Avenue Alain Savary, 21000 Dijon, France., Vimont D; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France., Hindié E; Nuclear Medicine Department, Bordeaux University Hospital, 33000 Bordeaux, France.; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France.; Institut Universitaire de France (IUF), 75231 Paris, France., Morgat C; Nuclear Medicine Department, Bordeaux University Hospital, 33000 Bordeaux, France.; INCIA, University of Bordeaux, CNRS, EPHE, UMR 5287, 33000 Bordeaux, France.

Publikováno v: Cancers [Cancers (Basel)] 2023 Apr 18; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 18.

Novel radiolabelled neurotensin analogues containing silylated amino acid for improved neurotensin receptor-1 (NTS1) targeting

Autor: Chastel, A, Fanelli, R, Previti, S, Vimont, D, Zanotti-Fregonara, P, Guillet, B, Garrigue, P, Balasse, L, FERNANDEZ, P, Remond, E, Hindie, E, Cavelier, F, Morgat, C

Publikováno v: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
32. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)
32. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2019, Barcelone, Spain

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c38f8d0c032c209191ab7c3e0478b701
https://hal.inrae.fr/hal-02899963

Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.

Autor: Vivancos M; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: melanie.vivancos@usherbrooke.ca., Fanelli R; Institut des Biomolécules Max Mousseron (IBMM), UMR-CNRS 5247, Université Montpellier, ENSCM, Montpellier, France. Electronic address: robyfanelli@hotmail.it., Besserer-Offroy É; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: ebesserer@mednet.ucla.edu., Beaulieu S; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: sabrina.beaulieu@usherbrooke.ca., Chartier M; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada., Resua-Rojas M; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: martin.resua-rojas@usherbrooke.ca., Mona CE; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA, USA. Electronic address: cmona@mednet.ucla.edu., Previti S; Institut des Biomolécules Max Mousseron (IBMM), UMR-CNRS 5247, Université Montpellier, ENSCM, Montpellier, France. Electronic address: spreviti@unime.it., Rémond E; Institut des Biomolécules Max Mousseron (IBMM), UMR-CNRS 5247, Université Montpellier, ENSCM, Montpellier, France. Electronic address: emmanuelle.remond@umontpellier.fr., Longpré JM; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: jean-michel.longpre@usherbrooke.ca., Cavelier F; Institut des Biomolécules Max Mousseron (IBMM), UMR-CNRS 5247, Université Montpellier, ENSCM, Montpellier, France. Electronic address: florine.cavelier@umontpellier.fr., Sarret P; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada; Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, Canada. Electronic address: philippe.sarret@usherbrooke.ca.

Publikováno v: Behavioural brain research [Behav Brain Res] 2021 May 07; Vol. 405, pp. 113189. Date of Electronic Publication: 2021 Feb 17.